| Drug repurposing: a promising tool to accelerate the drug discovery process V Parvathaneni, NS Kulkarni, A Muth, V Gupta Drug discovery today 24 (10), 2076-2085, 2019 | 483 | 2019 |
| Utilizing drug repurposing against COVID-19–efficacy, limitations, and challenges V Parvathaneni, V Gupta Life sciences 259, 118275, 2020 | 131 | 2020 |
| Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer B Vaidya, V Parvathaneni, NS Kulkarni, SK Shukla, JK Damon, A Sarode, ... International journal of biological macromolecules 122, 338-347, 2019 | 128 | 2019 |
| Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer X Wang, V Parvathaneni, SK Shukla, NS Kulkarni, A Muth, NK Kunda, ... International Journal of Biological Macromolecules 164, 638-650, 2020 | 90 | 2020 |
| Metformin-encapsulated liposome delivery system: an effective treatment approach against breast cancer SK Shukla, NS Kulkarni, A Chan, V Parvathaneni, P Farrales, A Muth, ... Pharmaceutics 11 (11), 559, 2019 | 76 | 2019 |
| Development of inhalable quinacrine loaded bovine serum albumin modified cationic nanoparticles: Repurposing quinacrine for lung cancer therapeutics B Vaidya, NS Kulkarni, SK Shukla, V Parvathaneni, G Chauhan, ... International journal of pharmaceutics 577, 118995, 2020 | 73 | 2020 |
| Systematic development and optimization of inhalable pirfenidone liposomes for non-small cell lung cancer treatment V Parvathaneni, NS Kulkarni, SK Shukla, PT Farrales, NK Kunda, A Muth, ... Pharmaceutics 12 (3), 206, 2020 | 72 | 2020 |
| Sorafenib loaded inhalable polymeric nanocarriers against non-small cell lung cancer SK Shukla, NS Kulkarni, P Farrales, DD Kanabar, V Parvathaneni, ... Pharmaceutical research 37, 1-19, 2020 | 60 | 2020 |
| Afatinib-loaded inhalable PLGA nanoparticles for localized therapy of non-small cell lung cancer (NSCLC)—development and in-vitro efficacy RS Elbatanony, V Parvathaneni, NS Kulkarni, SK Shukla, G Chauhan, ... Drug delivery and translational research 11, 927-943, 2021 | 59 | 2021 |
| Tyrosine kinase inhibitor conjugated quantum dots for non-small cell lung cancer (NSCLC) treatment NS Kulkarni, V Parvathaneni, SK Shukla, L Barasa, JC Perron, ... European Journal of Pharmaceutical Sciences 133, 145-159, 2019 | 58 | 2019 |
| Enhanced solubility, stability, permeation and anti-cancer efficacy of Celastrol-β-cyclodextrin inclusion complex SK Shukla, A Chan, V Parvathaneni, DD Kanabar, K Patel, S Ayehunie, ... Journal of Molecular Liquids 318, 113936, 2020 | 48 | 2020 |
| Cyclodextrin complexation for enhanced stability and non-invasive pulmonary delivery of resveratrol—applications in non-small cell lung cancer treatment X Wang, V Parvathaneni, SK Shukla, DD Kanabar, A Muth, V Gupta Aaps Pharmscitech 21, 1-14, 2020 | 47 | 2020 |
| Development of pharmaceutically scalable inhaled anti-cancer nanotherapy–repurposing amodiaquine for non-small cell lung cancer (NSCLC) V Parvathaneni, NS Kulkarni, G Chauhan, SK Shukla, R Elbatanony, ... Materials Science and Engineering: C 115, 111139, 2020 | 41 | 2020 |
| Metformin-loaded chitosomes for treatment of malignant pleural mesothelioma–a rare thoracic cancer SK Shukla, A Chan, V Parvathaneni, V Gupta International Journal of Biological Macromolecules 160, 128-141, 2020 | 39 | 2020 |
| Repurposing bedaquiline for effective non-small cell lung cancer (NSCLC) therapy as inhalable cyclodextrin-based molecular inclusion complexes V Parvathaneni, RS Elbatanony, M Goyal, T Chavan, N Vega, S Kolluru, ... International journal of molecular sciences 22 (9), 4783, 2021 | 29 | 2021 |
| Nanotechnology based repositioning of an anti-viral drug for non-small cell lung cancer (NSCLC) V Parvathaneni, M Goyal, NS Kulkarni, SK Shukla, V Gupta Pharmaceutical Research 37, 1-21, 2020 | 25 | 2020 |
| Inhaled indomethacin-loaded liposomes as potential therapeutics against non-small cell lung cancer (NSCLC) S Sarvepalli, V Parvathaneni, G Chauhan, SK Shukla, V Gupta Pharmaceutical Research 39 (11), 2801-2815, 2022 | 23 | 2022 |
| Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation–Evaluation of intestinal absorption and anti-cancer activity V Parvathaneni, RS Elbatanony, SK Shukla, NS Kulkarni, DD Kanabar, ... Journal of Molecular Liquids 327, 114866, 2021 | 18 | 2021 |
| Development and Characterization of Folic Acid-Conjugated Amodiaquine-Loaded Nanoparticles–Efficacy in Cancer Treatment V Parvathaneni, SK Shukla, V Gupta Pharmaceutics 15 (3), 1001, 2023 | 16 | 2023 |
| Development and characterization of inhalable transferrin functionalized amodiaquine nanoparticles–Efficacy in Non-Small Cell Lung Cancer (NSCLC) treatment V Parvathaneni, SK Shukla, NS Kulkarni, V Gupta International Journal of Pharmaceutics 608, 121038, 2021 | 16 | 2021 |
Vivek Gupta, Ph.D.Associate Professor, Pharmaceutical Sciences, St. John's University College of PharmacyAdresse e-mail validée de stjohns.edu
